Literature DB >> 17914412

Lymphoma microenvironment: culprit or innocent?

B Herreros1, A Sanchez-Aguilera, M A Piris.   

Abstract

Studies are revealing that lymphoid neoplasms are characterized by well-defined chromosome translocations and by the accumulation of subsequent molecular alterations involving mainly the cell cycle and/or apoptotic pathways. However, survival of B and T tumor cells is also dependent on the interactions with the accompanying cells that comprise the lymphoma microenvironment. Although non-tumor cells can contribute both positive and negative signals to the lymphoma cells, in this review we present compelling evidence of the essential influence of the tumor microenvironment on the initiation and progression of specific lymphoma types, highlighting some new therapeutic approaches that target the lymphoma microenvironment.

Entities:  

Mesh:

Year:  2007        PMID: 17914412     DOI: 10.1038/sj.leu.2404970

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  25 in total

1.  Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols.

Authors:  Daphne de Jong; Ad Koster; Anton Hagenbeek; John Raemaekers; Dennis Veldhuizen; Sabien Heisterkamp; Jan Paul de Boer; Martine van Glabbeke
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

2.  Immune Regulation by Self-Recognition: Novel Possibilities for Anticancer Immunotherapy.

Authors:  Mads Hald Andersen
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

Review 3.  Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.

Authors:  Mads Hald Andersen
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

Review 4.  CAR therapy for hematological cancers: can success seen in the treatment of B-cell acute lymphoblastic leukemia be applied to other hematological malignancies?

Authors:  Hollie J Pegram; Eric L Smith; Sarwish Rafiq; Renier J Brentjens
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

Review 5.  The tumor microenvironment shapes hallmarks of mature B-cell malignancies.

Authors:  K H Shain; W S Dalton; J Tao
Journal:  Oncogene       Date:  2015-02-02       Impact factor: 9.867

6.  Microfluidic assembly of hydrogel-based immunogenic tumor spheroids for evaluation of anticancer therapies and biomarker release.

Authors:  Pooja Sabhachandani; Saheli Sarkar; Seamus Mckenney; Dashnamoorthy Ravi; Andrew M Evens; Tania Konry
Journal:  J Control Release       Date:  2018-12-12       Impact factor: 9.776

7.  High ratio of interfollicular CD8/FOXP3-positive regulatory T cells is associated with a high FLIPI index and poor overall survival in follicular lymphoma.

Authors:  Majda Saifi; Aurélie Maran; Pierre Raynaud; Marie Christine Picot; Philippe Quittet; Guillaume Cartron; Jean François Rossi; Valérie Costes
Journal:  Exp Ther Med       Date:  2010-09-01       Impact factor: 2.447

8.  Evaluation of significance of lymphocyte subpopulations and non-specific serologic markers in B-cell non-Hodgkin's lymphoma patients.

Authors:  Éva Pósfai; Gábor Irsai; Árpád Illés; Gábor Méhes; Imelda Marton; Csaba Molnár; István Csípő; Sándor Baráth; Lajos Gergely
Journal:  Pathol Oncol Res       Date:  2014-02-01       Impact factor: 3.201

Review 9.  The B-cell receptor orchestrates environment-mediated lymphoma survival and drug resistance in B-cell malignancies.

Authors:  K H Shain; J Tao
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

10.  Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity.

Authors:  Shyamesh Kumar; Joram J Buza; Shane C Burgess
Journal:  Cancer Microenviron       Date:  2009-03-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.